Rallybio Corporaton (RLYB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6401 -0.0649 (-9.21%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6401 unch (unch) 16:00 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
Cash Flows From Operating Activities | |||||
Net Income | -54,322 | -35,948 | -17,318 | -66,654 | -50,451 |
Depreciation Amortization | -2,318 | -1,652 | -856 | -268 | 155 |
Accounts payable and accrued liabilities | -623 | -387 | -295 | 487 | 95 |
Other Working Capital | -1,779 | -1,066 | -4,199 | -936 | 210 |
Other Operating Activity | 10,422 | 6,904 | 3,903 | 10,087 | 7,971 |
Operating Cash Flow | $-48,620 | $-32,149 | $-18,765 | $-57,284 | $-42,020 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | N/A | N/A | -54 | -54 |
Purchase Of Investment | -97,175 | -62,353 | -30,035 | -201,616 | -136,970 |
Sale Of Investment | 107,924 | 70,032 | 31,500 | 89,500 | 55,500 |
Investing Cash Flow | $10,749 | $7,679 | $1,465 | $-112,170 | $-81,524 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 209 | 209 | N/A | 51,771 | 21 |
Other Financing Activity | -138 | -138 | -139 | -693 | -100 |
Financing Cash Flow | $71 | $71 | $-139 | $51,078 | $-79 |
Beginning Cash Position | 56,958 | 56,958 | 56,958 | 175,334 | 175,334 |
End Cash Position | 19,158 | 32,559 | 39,519 | 56,958 | 51,711 |
Net Cash Flow | $-37,800 | $-24,399 | $-17,439 | $-118,376 | $-123,623 |
Free Cash Flow | |||||
Operating Cash Flow | -48,620 | -32,149 | -18,765 | -57,284 | -42,020 |
Capital Expenditure | N/A | N/A | N/A | -54 | -54 |
Free Cash Flow | -48,620 | -32,149 | -18,765 | -57,338 | -42,074 |